Matching eligible patients to appropriate clinical trials remains a major challenge in healthcare due to large, heterogeneous datasets and complex eligibility criteria. This paper proposes a novel Quantum Machine Learning (QML) algorithm integrated with Natural Language Processing (NLP) techniques to optimize clinical trial matching. Unlike traditional methods, the proposed framework introduces a hybrid quantum–classical pseudocode workflow that combines quantum feature mapping with NLP-based data extraction to improve accuracy and efficiency in patient–trial matching. To strengthen the foundation of the proposed approach, key patented technologies, such as US20200005906A1 (intelligent patient–trial data matching) and US20220068443A1 (NLP-based eligibility interpretation), have been considered, demonstrating the growing feasibility of automated matching systems. The novelty of our work lies in unifying these advances within a scalable QML–NLP framework that reduces manual workload, shortens trial recruitment times, and improves overall research efficiency. By integrating quantum computing with NLP, this study moves beyond existing reviews and provides a concrete, implementable methodology to accelerate patient recruitment and advance personalized medicine.
Matching eligible patients to appropriate clinical trials remains a major challenge in healthcare due to large, heterogeneous datasets and complex eligibility criteria. This paper proposes a novel Quantum Machine Learning (QML) algorithm integrated with Natural Language Processing (NLP) techniques to optimize clinical trial matching. Unlike traditional methods, the proposed framework introduces a hybrid quantum–classical pseudocode workflow that combines quantum feature mapping with NLP-based data extraction to improve accuracy and efficiency in patient–trial matching. To strengthen the foundation of the proposed approach, key patented technologies, such as US20200005906A1 (intelligent patient–trial data matching) and US20220068443A1 (NLP-based eligibility interpretation), have been considered, demonstrating the growing feasibility of automated matching systems. The novelty of our work lies in unifying these advances within a scalable QML–NLP framework that reduces manual workload, shortens trial recruitment times, and improves overall research efficiency. By integrating quantum computing with NLP, this study moves beyond existing reviews and provides a concrete, implementable methodology to accelerate patient recruitment and advance personalized medicine.
Clinical trials represent one of the most resource-intensive and time-consuming phases of drug development, often constrained by complex patient stratification, high attrition rates, and logistical inefficiencies. Recent advances in quantum computing introduce new computational paradigms capable of addressing combinatorial optimization, probabilistic modeling, and high-dimensional data analysis challenges inherent in clinical research. This paper examines clinical trial optimization via quantum computing, exploring how quantum algorithms and hybrid quantum–classical frameworks can enhance patient recruitment, adaptive trial design, biomarker discovery, and outcome prediction. By synthesizing developments in quantum optimization, machine learning, and biomedical data analytics, the study evaluates the feasibility and potential impact of quantum-enabled methodologies in accelerating drug development pipelines. The findings suggest that quantum computing, when strategically integrated with classical infrastructures, may reduce development timelines, improve decision accuracy, and support more personalized and efficient clinical trial processes.
The healthcare industry is undergoing a fundamental revolution with the integration of Quantum Natural Language Processing techniques for matching patient-clinical trials. This research envisions a paradigm where patients and clinical trials collaborate, changing the way healthcare is supplied and medical research is conducted. Apart from this, the research focuses on engaging patients in clinical trials. Patient involvement refers to the process by which patients and their healthcare providers collaborate to make decisions regarding their health. Within the framework of clinical studies, this may entail participants providing input on study designs or monitoring their data through wearable technology and smartphone apps. Quantum NLP has the potential to enhance patient outcomes and advance medical knowledge more quickly by enabling more precise and effective clinical trials. By setting the framework for future applications of quantum NLP, this study expands the conversation on the connection between quantum computing and healthcare.
The growing digitalization of medical diagnostics has resulted in massive amounts of complicated data, including medical imaging and genomic sequences, clinical writing and real-time patient monitoring. Classical machine learning (CML) has achieved amazing success in evaluating such data. But its computational restrictions hinder scalability and efficiency when dealing with high-dimensional biomedical problems. Quantum machine learning (QML) combines the principles of quantum computing (QC) with advanced learning algorithms to offer a transformative paradigm for digital healthcare. This paper provides a systematic overview of QML foundations including quantum data encoding (QDC), variational quantum circuits (VQC), kernel methods, and hybrid quantum classical models. This paper also focuses on their applications in medical imaging, genomics, natural language processing (NLP) for electronic health records, drug discovery and healthcare security. We present comparative insights between classical and quantum approaches such as slow processing of high-dimensional data, limited scalability and inefficiency in complex optimization problems. This review also emphasizes the emerging directions towards quantum-based personalized digital healthcare approaches. By combining medical science with quantum QML has the potential to revolutionize the future of precision diagnostics, treatment optimization and healthcare data security. This study also provides a valuable resource for those interested in quantum computing and researchers who want to stay updated on the fast-growing area.
The rapid growth of Electronic Health Records (EHRs), along with the need for accurate, real-time clinical documentation, has pushed traditional computing methods to their operational limits. Conventional machine learning techniques often fall short when handling the heterogeneous, high-dimensional nature of healthcare data—especially in situations where clinical decisions must be made quickly and reliably. To overcome these challenges, this study introduces a Quantum Computing–Enabled Clinical Decision Support System (QC-CDSS), which integrates quantum machine learning (QML) with advanced deep learning models to improve diagnostic accuracy and predictive performance. The proposed framework utilizes quantum-driven feature extraction, hybrid variational quantum circuits, and quantum kernel-based classifiers to process both structured EHR records and unstructured clinical narratives. In parallel, sophisticated natural language processing methods, including transformer-based architectures, are employed to capture semantic, contextual, and temporal patterns from physician notes, discharge summaries, radiology interpretations, and related clinical text. The convergence of these techniques—particularly the integration of QML—presents promising opportunities for achieving more effective decision support and faster analysis of high-dimensional medical data. This paper discusses the core concepts, major applications, existing challenges, and future research pathways for incorporating quantum-enhanced machine learning into clinical decision-making systems, emphasizing their potential to address complex healthcare problems more efficiently.
The rapid advancements in artificial intelligence (AI) and quantum computing have catalyzed an unprecedented shift in the methodologies utilized for healthcare diagnostics and treatment optimization. This research paper explores the integration of quantum neural networks (QNNs) with classical machine learning (ML) algorithms to enhance diagnostic accuracy, facilitate personalized treatment plans, and predict patient outcomes with a higher degree of precision. Quantum neural networks, leveraging the principles of quantum mechanics such as superposition, entanglement, and quantum parallelism, have demonstrated the potential to perform complex computations more efficiently than classical counterparts. When coupled with established machine learning algorithms, QNNs can overcome traditional limitations in data processing, enabling more sophisticated models capable of uncovering intricate patterns in large and high-dimensional datasets. Machine learning, with its vast applications in the medical field, has long been instrumental in improving diagnostics and tailoring treatment regimens to patient-specific characteristics. However, despite significant advancements, classical ML approaches face substantial challenges, particularly in terms of computational complexity and the ability to process large-scale, multi-modal healthcare data effectively. Quantum neural networks address these challenges by introducing quantum computational paradigms that facilitate exponentially faster processing, allowing for real-time analysis of vast and complex datasets. The synergy between QNNs and ML algorithms introduces novel approaches that are poised to revolutionize predictive analytics in healthcare, optimizing patient outcomes and enabling highly personalized treatment plans. A key aspect of integrating quantum neural networks into machine learning frameworks is the potential for improved precision in diagnostic systems. Traditional diagnostic procedures often rely on predefined models that may overlook nuanced correlations within patient data. Quantum neural networks, with their ability to represent and process data in a quantum space, provide a more robust framework that can adaptively learn from intricate relationships in patient information. For instance, QNNs can significantly enhance the efficacy of disease detection algorithms, such as those used for identifying early-stage cancers or predicting the onset of chronic conditions like diabetes and heart disease, by offering superior pattern recognition capabilities. Furthermore, QNNs combined with classical machine learning architectures facilitate the creation of hybrid models that harness the strengths of both approaches, leading to diagnostic tools that are not only more precise but also more adaptive to varied data sources. The integration of QNNs with machine learning extends beyond diagnostics to personalized treatment optimization. Traditional treatment planning methodologies, including rule-based and data-driven ML models, often face difficulties in accounting for the multifaceted nature of patient data and individual variability. Quantum neural networks enhance this process by leveraging quantum algorithms that provide an efficient search space for complex treatment optimization problems, allowing for a more detailed understanding of patient responses and potential treatment outcomes. The ability of QNNs to perform parallel processing enables the assessment of a wide range of treatment scenarios simultaneously, leading to more accurate predictions regarding patient reactions to specific drugs, therapies, or medical interventions. This facilitates an adaptive approach that can recommend personalized treatment regimens based on comprehensive patient profiles, ultimately enhancing patient outcomes and reducing the likelihood of adverse drug reactions. In addition to enhancing diagnostics and treatment recommendations, quantum neural networks show promise in forecasting patient outcomes by offering a more robust analysis of longitudinal patient data. Forecasting models that leverage the combined power of quantum and classical algorithms can process historical data more rapidly, allowing healthcare providers to anticipate potential health issues and intervene earlier. For example, predictive models utilizing QNNs can anticipate patient deterioration in critical care settings, facilitating timely interventions that mitigate risks and improve survival rates. Such predictive models can be instrumental in managing chronic diseases, monitoring recovery trajectories, and optimizing resource allocation within healthcare systems, thus contributing to overall efficiency and better resource management. Despite the promising capabilities of integrating QNNs with ML algorithms, there are notable challenges that need to be addressed to fully realize their potential. The practical implementation of quantum algorithms in a healthcare context faces hurdles related to hardware limitations, the need for high fidelity in quantum states, and the scalability of quantum systems to handle real-world clinical data. Additionally, the hybrid nature of combining classical and quantum approaches requires sophisticated algorithms that can bridge the gap between quantum computation and classical data processing pipelines. Solutions to these challenges may include advancements in quantum hardware, such as the development of more stable qubits and noise reduction techniques, as well as the optimization of hybrid algorithms that leverage both classical machine learning and quantum computing capabilities effectively. The exploration of quantum neural networks for healthcare applications also necessitates rigorous ethical considerations, particularly in ensuring data privacy and security. The incorporation of quantum computing must comply with healthcare data protection regulations, and quantum algorithms must be designed to maintain patient confidentiality while processing sensitive health data. Moreover, the interpretability of quantum models poses challenges that could hinder their acceptance in clinical practice. Advances in explainable AI and quantum algorithm transparency are crucial to foster trust among healthcare professionals and patients alike. Integration of quantum neural networks with classical machine learning models represents a transformative approach that could significantly advance healthcare diagnostics, personalized treatment strategies, and patient outcome prediction. By harnessing the computational advantages offered by quantum systems and the flexibility of machine learning algorithms, healthcare applications can achieve a new level of precision and adaptability. Despite current challenges, continued research into quantum algorithms, quantum hardware development, and hybrid computational models promises substantial strides in overcoming these limitations. The synergy between QNNs and ML algorithms could ultimately lead to more effective, personalized, and efficient healthcare solutions, ushering in a new era of data-driven medical care characterized by increased diagnostic accuracy and improved treatment outcomes. As the field evolves, interdisciplinary collaboration between quantum physicists, computer scientists, and healthcare professionals will be vital to unlock the full potential of these innovative computational techniques and bring them to mainstream clinical use.
By facilitating quicker and more precise analysis of intricate biological data, the union of quantum computing and Artificial Intelligence (AI) may transform genomic medicine and drug discovery altogether. The study suggests a model for artificial intelligence with quantum-enhanced acceleration based on hybrid quantum-classical models in order to speed up drug discovery and customize therapies. It utilizes deep learning models and Quantum Machine Learning (QML) techniques to analyze patient-specific data, protein structures, and genetic sequences. Large genomic and clinical data sets are processed by conventional deep learning models, while the quantum component carries out efficient data encoding and optimization processes. As compared to other traditional AI-based approaches, the proposed model performs a 30% improved drug target identification when evaluated against more than 1,000 genetic sequences and related clinical outcomes. The hybrid model was as accurate as 98.4% in its prediction and was more accurate than the conventional AI techniques including random forests (accuracy: 91.3%) and gradient boosting machines (accuracy: 93.7%). The methodology also produced an F1-score of 0.95 with accuracy and recall scores of 96.1% and 94.7%, respectively. These results demonstrate how quantum-enhanced AI can reduce the time for computation and improve the accuracy of genomic data analysis, driving significant progress toward personalized therapy and drug development.